Confirmed best overall response per Response Evaluation Criteria in Solid Tumors V.1.1 assessed by IRC and investigator
| Response | N=153 | |
| IRC assessed | Investigator assessed | |
| Confirmed best overall response, n (%) | ||
| CR | 2 (1.3) | 5 (3.3) |
| PR | 12 (7.8) | 15 (9.8) |
| Stable disease | 46 (30.1) | 50 (32.7) |
| Non-CR/non-progressive disease | 1 (0.7) | 0 |
| Progressive disease | 67 (43.8) | 66 (43.1) |
| Non-evaluable* | 25 (16.3) | 17 (11.1) |
| ORR (%)† (95% CI) | 9.2 (5.1 to 14.9) | 13.1 (8.2 to 19.5) |
*Includes missing and not assessable.
†Defined as the proportion of patients with a CR or PR.
CR, complete response; IRC, independent review committee; ORR, objective response rate; PR, partial response.